Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study

Sleep Medicine

Volumn 11, Issue 1, 2010, Pages 11-16

  Inoue, Yuichi ^a,b   Hirata, Koichi ^c   Kuroda, Kenji ^d   Fujita, Masahiko ^e   Shimizu, Tetsuo ^f   Emura, Narutsugu ^g   Uchimura, Naohisa ^h   Kagimura, Tatsuo ⁱ   Sha, Koji ⁱ   Nozawa, Taneyoshi ^j  

^a NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d Hannan Hospital   (Japan)

^e Wellness Bouyoudai Clinic   (Japan)

^f AKITA UNIVERSITY   (Japan)

^g OSAKA MEDICAL COLLEGE   (Japan)

^h KURUME UNIVERSITY   (Japan)

ⁱ NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^j TORANOMON HOSPITAL   (Japan)

more..

Author keywords

Epworth sleepiness scale (ESS); Periodic limb movements (PLM); Pittsburgh Sleep Quality Index (PSQI); Pramipexole; Restless legs syndrome (RLS); Suggested immobilization test (SIT); The International Restless Legs Syndrome Study Group rating scale (IRLS)

Indexed keywords

PLACEBO; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMOBILIZATION; JAPANESE; LIMB MOVEMENT; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; SLEEP DISORDER;

ADULT; AGED; AROUSAL; BENZOTHIAZOLES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RESTLESS LEGS SYNDROME; SLEEP STAGES; TREATMENT OUTCOME; WAKEFULNESS;

EID: 73149087895     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.03.009     Document Type: Article

References (26)

1. Carter A.J., and Mueller R.E. Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo. Eur J Pharmacol 200 1 (1991) 65-72
2. Piercey M.F., Hoffmann W.E., Smith M.W., and Hyslop D.K. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists. Eur J Pharmacol 312 1 (1996) 35-44
3. Mierau J., and Schingnitz G. Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Eur J Pharmacol 215 2/3 (1992) 161-170
4. Michaud M., Poirier G., Lavigne G., and Montplaisir J. Restless legs syndrome: scoring criteria for leg movements recorded during the suggested immobilization test. Sleep Med 2 (2001) 317-321
5. Michaud M., Lavigne G., Desautels A., Poirier G., and Montplaisir J. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord 17 1 (2002) 112-115
6. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., and Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989) 193-213
7. Doi Y., Minowa M., Uchiyama M., Okawa M., Kim K., Shibui K., et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 97 (2000) 165-172
8. Doi Y., Minowa M., Uchiyama M., and Okawa M. Development of the Pittsburgh Sleep Quality Index. Original in Japanese. Jpn J Psychiatry Treat 13 6 (1998) 755-763
9. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 2 (2003) 101-119
10. Partinen M., Hirvonen K., Jama L., Alakuijala A., Hublin C., Tamminen I., et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study - The PRELUDE study. Sleep Med 7 (2006) 407-417
11. In: Rechtschaffen A., and Kales A. (Eds). A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects (1968), US Department of Health, Education, and Welfare, Public Health Service - National Institute of Health - National Institute of Neurological Diseases and Blindness - Neurological Information Network, Bethesda
12. The Atlas Task Force. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 15 (1992) 173-184
13. Bonnet M., Carley D., Carskadon M., Easton P., Guilleminault C., Harper R., et al. Atlas Task Force. Recording and scoring leg movements. APSS Natl Mtg, 1992. Sleep 16 8 (1993) 749-759
14. .
15. National Institute of Mental Health (NIMH), Early clinical drug evaluation unit (ECDEU). Clinical global impressions. In: W. Guy, editor. ECDEU assessment manual for psychopharmacology (rev.), NIMH USA, Rockville, MD; 1976.
16. Johns M.W. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 14 6 (1991) 540-545
17. Imura H. Insomnia and excessive sleepiness. Intern Med (Tokyo) 2 (2002) 1094-1105
18. Hening W.A. Current guidelines and standards of practice for restless legs syndrome. Am J Med 120 (2007) S22-S27
19. Allen R.P., and Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 2 (2001) 128-147
20. Ancoli-Israel S., Kripke D.F., Klauber M.R., Mason W.J., Fell R., and Kaplan O. Periodic limb movements in sleep in community-dwelling elderly. Mtg of the Association of Professional Sleep Societies. Sleep 14 6 (1991) 496-500
21. Rascol O., Brooks D.J., Korczyn A.D., De Deyn P.P., Clarke C.E., and Lang A.E. A five year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa (056 study group). N Engl J Med 342 20 (2000) 1484-1491
22. Parkinson Study Group. Pramipexole vs. levodopa as initial treatment for Parkinson disease. A randomized controlled trial. JAMA 284 15 (2000) 1931-1938
23. Oertel W.H., Wolters E., Sampaio C., Gimenez-Roldan S., Bergamasco B., Dujardin M., et al. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: the PELMOPET study. Mov Disord 21 3 (2006) 343-353
24. Winkelman J.W., Sethi K.D., Kushida C.A., Becker P.M., Koester J., Cappola J.J., et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 67 (2006) 1034-1039
25. Trenkwalder C., Stiasny-Kolster K., Kupsch A., Oertel W.H., Koester J., Reess J., and The German RLS-Pramipexole Study Group. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord 21 9 (2006) 1404-1410
26. Inoue Y, Oka Y, Matsuda H, Kagimura T, Kuroda K, Hirata K, et al. The reliability, validity and responsiveness of Japanese version of the Restless Legs Syndrome Rating Scale in a clinical-trial setting. Sleep Med, submitted for publication.